Business ResultsFirst Nine Months of the Fiscal Year Ending March 31, 2026

from the beginning

Business Results First Nine Months of the Fiscal Year Ending March 31, 2026

• Disclaimer

• Index

1. Executive Summary

• Executive Summary -1

• Executive Summary -2

2. Business Results, First Nine Months of the Fiscal Year Ending March 31, 2026

• Financial Highlights (Year on Year)

• Breakdown of Net Sales (by Business and Field)

• Breakdown of Net Sales (by Destination and Product Type)

• Information by Destination (Americas)

• Information by Destination (EMEA)

• Information by Destination (China)

• Outlook for China

• Information by Destination (AP)

• Information by Destination (Japan)

• Breakdown of Operating Profit (Year on Year)

3. Growth Strategy Progress Reinforcement of Existing Businesses, Emerging Market Strategies, Expansion of New Businesses

• Three Growth Strategies: Reinforcement of Existing Businesses(Hemostasis Field)

• Three Growth Strategies: Reinforcement of Existing Businesses (Immunochemistry Field)

• Three Growth Strategies: Emerging Market Strategy

• Three Growth Strategies: Expansion of New Businesses(Medical Robotics Business)

4. Financial Forecast for the Fiscal Year Ending March 31, 2026

• Revised Financial Forecast for the Fiscal Year Ending March 31, 2026 -1

• Revised Financial Forecast for the Fiscal Year Ending March 31, 2026 -2

• Quarterly Results and Forecast for the Fiscal Year Ending March 31, 2026

• Cost of Sales Ratio by Quarter, and Outlook for the Fiscal Year EndingMarch 31, 2026

• Reference: Financial Forecast for the Fiscal Year Ending March 31, 2026(Sales by Business, Field, and Destination)

5. Looking Ahead to the Next Mid-Term Management Plan

• Key Points of the Next Medium-Term Management Plan

(Appendix)

• Highlights (October 2025 to January 2026)

@